Загрузка...
Fatal interstitial lung disease associated with icotinib
The most serious, and maybe fatal, yet rare, adverse reaction of gefitinib and erlotinib is drug-associated interstitial lung disease (ILD), which has been often described. However, it has been less well described for icotinib, a similar orally small-molecule tyrosine kinase inhibitor (TKI). The cas...
Сохранить в:
| Опубликовано в: : | J Thorac Dis |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Pioneer Bioscience Publishing Company
2014
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4283337/ https://ncbi.nlm.nih.gov/pubmed/25590006 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2072-1439.2014.10.24 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|